✦ LIBER ✦

Safety of Hexaminolevulinate for Blue Light Cystoscopy in Bladder Cancer. A Combined Analysis of the Trials Used for Registration and Postmarketing Data

✍ Scribed by Witjes, J. Alfred; Gomella, Leonard G.; Stenzl, Arnulf; Chang, Sam S.; Zaak, Dirk; Grossman, H. Barton

Book ID: 122124210
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 149 KB
Volume: 84
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2014.03.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase III, Multicenter Comparison of H

A Phase III, Multicenter Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Superficial Papillary Lesions in Patients With Bladder Cancer

✍ Grossman, H. Barton; Gomella, Leonard; Fradet, Yves; Morales, Alvaro; Presti, Jo 📂 Article 📅 2007 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 174 KB

A Comparison of Hexaminolevulinate Fluor

A Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Carcinoma In Situ in Patients With Bladder Cancer: A Phase III, Multicenter Study

✍ Fradet, Yves; Grossman, H. Barton; Gomella, Leonard; Lerner, Seth; Cookson, Mich 📂 Article 📅 2007 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 86 KB

Who should be included in a clinical tri

Who should be included in a clinical trial of screening for bladder cancer? : A decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial

✍ Andrew J. Vickers; Caroline Bennette; Adam S. Kibel; Amanda Black; Grant Izmirli 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 768 KB